Leslie Aberman, Vice President, Legal Affairs and Intellectual Property Samantha Willing, Vice President, People SEATTLE, Sept. 19, 2019 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to… Read More
SAN DIEGO, Sept. 11, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of novel cancer therapies, today announced that CEO Saiid Zarrabian… Read More
Company Estimates Cash Runway Sufficient to Report Top-Line Results from Two of Three Patient Groups in Phase 2 Trials By 4th Quarter of Calendar Year 2020 SAN DIEGO, Sept. 10,… Read More
Today AbCellera announced the expansion of its executive team with the hiring of Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel. In his role as CFO,… Read More
SAN DIEGO, Sept. 9, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of novel cancer therapies, today announced that on September 6,… Read More
